-
Study aim
-
The effect of misoprostol with isosorbide mononitrate on the induction of first-trimester abortion
-
Design
-
This study is a one-blinded clinical trial. The study population will be all less than 13 weeks pregnant who are candidates for termination of pregnancy referred to Imam Reza Hospital of Kermanshah.54 eligible patients will be selected conveniently and randomly assigned to two intervention and control groups.
-
Settings and conduct
-
This study that will be conducted in Imam Reza hospital of Kermanshah city is a one-blinded one that the data analyzer was kept blind to the allocation of study groups. At baseline, both groups were matched for age, gestational age, parity, gravidity, height, weight (BMI), and previous abortion.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Nullipara and multipara to 5 Parity and singleton women;
No history of previous cesarean section and uterine surgery;
Exclusion criteria: Women with open cervix and contraindication for isosorbide mononitrate (IMN); Women with significant heart disease or anemia
-
Intervention groups
-
In the intervention group, 40mg isosorbide mononitrate tablets will be placed in the posterior fornix. Then 4 hours later 800mcg of misoprostol, equivalent to four 200mcg tablets (manufactured by Aria Pharmaceuticals), in a single dose of the saline-will embedded posterior fornix.In the control group, 40 mg vitamin B6 (manufactured by Galinus) will be implanted in the vagina in the posterior fornix b then 4 hours later 800 mcg of misoprostol, equivalent to four 200 mg mcg tablets (manufactured by Aria) in a single dose of saline will embedded posterior fornix.
-
Main outcome variables
-
Time of cervical opening from induction onset, time of the secretion of pregnancy products from the onset of induction, complete abortion